Epigenetics: novel mechanism of pulmonary hypertension

Lung. 2013 Dec;191(6):601-10. doi: 10.1007/s00408-013-9505-1. Epub 2013 Sep 20.

Abstract

Introduction: Epigenetics refers to changes in phenotype and gene expression that occur without alterations in DNA sequence. MicroRNAs are relatively recently discovered negative regulators of gene expression and act at the posttranscriptional level.

Methods: This review summarizes epigenetic mechanisms of pulmonary hypertension, focusing on microRNAs related to pulmonary hypertension.

Results: There are three major mechanisms of epigenetic regulation, including methylation of CpG islands, modification of histone proteins, and microRNAs. There may be an epigenetic component to pulmonary hypertension. These epigenetic abnormalities can be reversed therapeutically.

Conclusions: By better integrating network biology with evolving technologies in cell culture and in vivo experimentation, we will better understand epigenetic mechanisms of pulmonary hypertension and identify more diagnostic and therapeutic targets in pulmonary hypertension.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / drug effects
  • Blood Pressure / genetics*
  • Chromatin Assembly and Disassembly
  • CpG Islands
  • DNA Methylation
  • Epigenesis, Genetic* / drug effects
  • Gene Expression Regulation
  • Genetic Predisposition to Disease
  • Genetic Therapy
  • Genomics
  • Histones / metabolism
  • Humans
  • Hypertension, Pulmonary / genetics*
  • Hypertension, Pulmonary / metabolism
  • Hypertension, Pulmonary / physiopathology
  • Hypertension, Pulmonary / therapy
  • MicroRNAs / metabolism
  • MicroRNAs / therapeutic use
  • Phenotype
  • Prognosis
  • Systems Biology

Substances

  • Antihypertensive Agents
  • Histones
  • MicroRNAs